Guardant Health Stock

Guardant Health Stock. Get the latest guardant health stock price and detailed information including gh news, historical charts and realtime prices. The shares were bought at an average cost of $94.36 per share, for a total transaction of $5,142,620.00.

Logos Guardant Health from guardanthealth.com

View the latest guardant health inc. Guardant health stock price target raised to $83 from $55 at svb leerink. Guardant health (gh) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it.

Source: fxdailyreport.com

Stock analysis for guardant health inc (gh:nasdaq gs) including stock price, stock chart, company news, key statistics, fundamentals and company profile. So it actually has us$90.0m more.

Source: sec.report

How strong is guardant health's balance sheet? Guardant health stock price target raised to $83 from $55 at svb leerink.

Source: guardanthealth.com

The average guardant health stock price prediction forecasts a potential upside of 136.38% from the current gh share price of $73.68. Also, ceo helmy eltoukhy acquired 54,500 shares of guardant health stock in a transaction dated tuesday, november 23rd.

Source: nai500.com

Transforming cancer care at all stages of the disease. Transforming cancer care at all stages of the disease.

Source: guardanthealth.com

The disclosure for this purchase can be found Offsetting these obligations, it had cash of us$1.49b as well as receivables valued at us$60.7m due within 12 months.

Source: www.cnbc.com

Is a precision oncology company. Guardant health inc nasdaq updated feb 16, 2022 5:45 pm.

Source: public.com

Guardant health share price volatility. Since then, gh stock has increased by 11.6% and is now trading at $70.25.

Source: guardanthealth.com

Fortunately the longer term story is brighter, with total returns averaging about 7% per year over three years. Of course the long term matters more than the short term, and even great stocks will sometimes have a poor year.

The Disclosure For This Purchase Can Be Found

On average, wall street analysts predict. How strong is guardant health's balance sheet? In other guardant health news, director stanley j.

Stock | Gh | Us40131M1099

(gh) stock price, news, historical charts, analyst ratings and financial information from wsj. Get the latest guardant health, inc. Filed pursuant to section 16 (a) of the securities exchange act of 1934 or section 30 (h) of the investment company act of 1940.

Offsetting These Obligations, It Had Cash Of Us$1.49B As Well As Receivables Valued At Us$60.7M Due Within 12 Months.

Issuer name and ticker or trading symbol guardant health, inc. The market (nasdaq average) beta is 1, while guardant health's is 0.4533. Guardant health, inc., a precision oncology company, provides blood tests, data sets, and analytics in the united states and internationally.

(Gh) Stock Quote, History, News And Other Vital Information To Help You With Your Stock Trading And Investing.

Also, ceo helmy eltoukhy acquired 54,500 shares of guardant health stock in a transaction dated tuesday, november 23rd. Since then, gh stock has increased by 11.6% and is now trading at $70.25. Guardant health (gh) stock price, news & info | the motley fool please ensure javascript is.

Gh Guardant Health Inc — Stock Price And Discussion | Stocktwits.

The shares were bought at an average cost of $94.36 per share, for a total transaction of $5,142,620.00. Guardant health share price volatility. 13, 2019 at 8:55 a.m.